Constellation Pharmaceuticals, Inc. Operating Income 2018-2021 | CNST
Constellation Pharmaceuticals, Inc. operating income from 2018 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Constellation Pharmaceuticals, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2020 | $-125 |
| 2019 | $-86 |
| 2018 | $-61 |
| 2017 | $-39 |
| 2016 | $-34 |
| Constellation Pharmaceuticals, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2021-03-31 | $-40 |
| 2020-12-31 | $-36 |
| 2020-09-30 | $-33 |
| 2020-06-30 | $-30 |
| 2020-03-31 | $-26 |
| 2019-12-31 | $-24 |
| 2019-09-30 | $-21 |
| 2019-06-30 | $-21 |
| 2019-03-31 | $-20 |
| 2018-12-31 | $-21 |
| 2018-09-30 | $-16 |
| 2018-06-30 | $-12 |
| 2018-03-31 | $-12 |
| 2017-09-30 | $-10 |
| 2017-06-30 | $-10 |
